Heron Therapeutics, Inc. · NASDAQ:HRTX
Clearline Capital LP reported a 6.70% stake in Heron Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Clearline Capital LP reported a 6.70% stake in Heron Therapeutics, Inc., 12,235,239 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 12,235,239
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Clearline Capital LP | 6.70% | 12,235,239 |
| Clearline Capital LLC | 6.70% | 12,235,239 |
| Marc Majzner | 6.70% | 12,235,239 |
Source
Related
- Heron Therapeutics, Inc.
- Clearline Capital LP
- Heron Therapeutics, Inc. shareholders
- Schedule 13G · Clearline Capital LP · Nov 26, 2025
- Form 4 · Collard Craig A · Oct 21, 2026
- Form 4 · Duarte Ira · Oct 21, 2026
- Form 4 · Forbes William P · Oct 21, 2026
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026